Evidence map›Paper›PMID 37566156›Full record

ArticleMetabolic brain disease2023

Saffron and crocin ameliorate prenatal valproic acid-induced autistic-like behaviors and brain oxidative stress in the male offspring rats.

Seyed Ali Seyedinia, Parnia Tarahomi, Davood Abbarin, Katayoun Sedaghat, Ali Rashidy-Pour, Habib Yaribeygi, Abbas Ali Vafaei, Payman Raise-Abdullahi

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolic brain disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Seyed Ali SeyediniaResearch Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran.ORCID 0000-0003-2715-1370
Parnia TarahomiResearch Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran.ORCID 0000-0001-5467-5642
Davood AbbarinResearch Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran.ORCID 0009-0006-8936-0273
Katayoun SedaghatResearch Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran.ORCID 0000-0001-5424-8640
Ali Rashidy-PourResearch Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran.ORCID 0000-0001-5006-1408
Habib YaribeygiResearch Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran.ORCID 0000-0002-1706-6212
Abbas Ali VafaeiResearch Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran. aavafaei@semums.ac.ir.ORCID 0000-0003-1178-3787
Payman Raise-AbdullahiResearch Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran. payman.raise.abdullahi@semums.ac.ir.ORCID 0000-0003-2262-735X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autism is a neurobehavioral disease that induces cognitive and behavioral alterations, usually accompanied by oxidative stress in the brain. Crocus sativus (saffron) and its active ingredient, crocin, have potent antioxidative effects that may benefit autistic behaviors. This study aimed to determine the effects of saffron extract and crocin against brain oxidative stress and behavioral, motor, and cognitive deficits in an animal model of autism in male offspring rats. 14 female rats were randomly divided into the saline and valproic acid (VPA) groups. Then, they were placed with mature male rats to mate and produce offspring. VPA (500 mg/kg, i.p.) was injected on day 12.5 of pregnancy (gestational day, GD 12.5) to induce an experimental model of autism. 48 male pups were left undisturbed for 29 days. First-round behavioral tests (before treatments) were performed on 30-33 post-natal days (PND), followed by 28 days of treatment (PND 34-61) with saffron (30 mg/kg, IP), crocin (15 or 30 mg/kg, i.p.), or saline (2 ml/kg, i.p.). The second round of behavioral tests (after treatments) was performed on PND 62-65 to assess the effects of the treatments on behavioral and cognitive features. In the end, animals were sacrificed under deep anesthesia, and their brains were dissected to evaluate the brain oxidative stress parameters, including malondialdehyde (MDA), glutathione (GSH), and catalase (CAT). VPA injection into female rats increased anxiety-like behaviors, enhanced pain threshold, impaired motor functions, disturbed balance power, increased MDA, and decreased GSH and CAT in their male offspring. 28 days of treatment with saffron or crocin significantly ameliorated behavioral abnormalities, reduced MDA, and increased GSH and CAT levels. Brain oxidative stress has been implicated in the pathophysiology of autistic-like behaviors. Saffron and crocin ameliorate anxiety-like behaviors, pain responses, motor functions, and brain oxidative stress parameters in an experimental model of autism. Saffron and crocin may hold promise as herbal-based pharmacological treatments for individuals with autism. However, further histological evidence is needed to confirm their efficacy.

Indexed as

Autistic DisorderCrocusPrenatal Exposure Delayed EffectsAnimalsBrainCarotenoidsDisease Models, AnimalFemaleGlutathioneHumansMaleOxidative StressPregnancyRatsRats, WistarValproic AcidCarotenoidscrocinGlutathioneValproic AcidAnxietyAutismCognitionCrocinOxidative stressSaffronValproic acid

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.